ANGPTL3 and hypertriglyceridemia: A previous study has demonstrated that the siRNA-mediated knockdown of liver ANGPTL3 relieved its inhibitory effect on LPL and significantly reduced hypertriglyceridemia and oxidative stress in nephrotic rats [29].